Oric Pharmaceuticals Inc
(ORIC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,444 | -19,896 | -8,872 | -26,883 | -18,529 |
| Depreciation Amortization | 769 | 496 | 250 | 1,028 | 758 |
| Other Working Capital | 672 | -371 | -184 | 1,220 | 727 |
| Other Operating Activity | 16,560 | 1,908 | 527 | 1,102 | 659 |
| Operating Cash Flow | $-27,443 | $-17,863 | $-8,279 | $-23,533 | $-16,385 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -124,640 | N/A | N/A | N/A | N/A |
| PPE Investments | -256 | -206 | -4 | N/A | -712 |
| Net Acquisitions | N/A | N/A | N/A | -768 | N/A |
| Other Investing Activity | 193 | 193 | 193 | 0 | 0 |
| Investing Cash Flow | $-124,703 | $-13 | $189 | $-768 | $-712 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 138,104 | 138,051 | 12 | 131 | 94 |
| Other Financing Activity | -13,086 | -12,692 | -1,639 | 70,693 | 70,791 |
| Financing Cash Flow | $125,018 | $125,359 | $-1,627 | $70,824 | $70,885 |
| Beginning Cash Position | 89,159 | 89,159 | 89,159 | 42,636 | 42,636 |
| End Cash Position | 62,031 | 196,642 | 79,442 | 89,159 | 96,424 |
| Net Cash Flow | $-27,128 | $107,483 | $-9,717 | $46,523 | $53,788 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,443 | -17,863 | -8,279 | -23,533 | -16,385 |
| Capital Expenditure | -256 | -206 | -4 | -768 | -712 |
| Free Cash Flow | -27,699 | -18,069 | -8,283 | -24,301 | -17,097 |